Campylobacter jejuni subsp. jejuni (Jones et al.) Veron and Chatelain (ATCC® BAA-529)

Strain Designations: INP59  /  Type Strain: no  /  Biosafety Level: 2

Strain Designations INP59
Application
Emerging infectious disease research
Enteric Research
Isolation
Patient with Guillain-Barre Syndrome, Mexico
By I Nachamkin and P Azarte, 1998
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Serotype HS:41
Product Format freeze-dried
Preceptrol® no
Type Strain no
Antigenic Properties Serotype HS:41
Medium ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37°C
Atmosphere: Microaerophilic (10% CO2, 3-5% O2)
Name of Depositor I Nachamkin
Isolation
Patient with Guillain-Barre Syndrome, Mexico
By I Nachamkin and P Azarte, 1998
Year of Origin 1998
References

Nachamkin I, et al. Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barre syndrome and gastroenteritis.. J. Infect. Dis. 184: 221-226, 2001. PubMed: 11400077

Engberg J, et al. Absence of clonality of Campylobacter jejuni in serotypes other than HS:19 associated with Guillain-Barre syndrome and gastroenteritis.. J. Infect. Dis. 184: 215-220, 2001. PubMed: 11400076